Advertisement

Topics

Moderna, Merck expand collaboration to develop & commercialise mRNA cancer vaccines

05:53 EDT 5 May 2018 | PharmaBiz

Moderna Therapeutics, a company discover and develop of messenger RNA (mRNA) therapeutics and vaccines, and Merck, known as MSD outside the United States and Canada, announced an expansion of their 2016 collaboration

Original Article: Moderna, Merck expand collaboration to develop & commercialise mRNA cancer vaccines

NEXT ARTICLE

More From BioPortfolio on "Moderna, Merck expand collaboration to develop & commercialise mRNA cancer vaccines"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...